HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615 | -60.7% | 16,088 | -62.9% | 0.01% | -57.6% |
| Q2 2023 | $1,563 | -5.6% | 43,326 | 0.0% | 0.03% | -5.7% |
| Q1 2023 | $1,655 | -32.9% | 43,326 | 0.0% | 0.04% | -36.4% |
| Q4 2022 | $2,465 | -99.9% | 43,326 | 0.0% | 0.06% | +34.1% |
| Q3 2022 | $1,713,000 | -10.1% | 43,326 | 0.0% | 0.04% | -4.7% |
| Q2 2022 | $1,906,000 | +10.3% | 43,326 | 0.0% | 0.04% | +26.5% |
| Q1 2022 | $1,728,000 | -40.4% | 43,326 | -39.9% | 0.03% | -29.2% |
| Q4 2021 | $2,900,000 | -1.2% | 72,126 | 0.0% | 0.05% | -9.4% |
| Q3 2021 | $2,934,000 | -10.4% | 72,126 | 0.0% | 0.05% | -8.6% |
| Q2 2021 | $3,275,000 | +41.2% | 72,126 | +29.7% | 0.06% | +48.7% |
| Q1 2021 | $2,319,000 | – | 55,626 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |